In addition to focusing on the Ministry of Health’s actions, the Covid do Senado CPI should expand the scope of the investigation to include other actors who have played a role in combating the novel coronavirus pandemic.
Senator Humberto Costa (PT-PE) said he intends to present requirements to hear CFM (Federal Board of Medicine) members and health plans on the committee. The aim is to investigate the role of these organs in the prevalence of so-called “early treatment”.
In the senator’s view, the Senate encouraged the use of the drugs without proving their effectiveness from the moment he allowed the doctor to make his own decision.
The CFM unofficially presented one of the scientific bases for President Jair Bolsonaro (without a party) to further publicize and defend the administration of hydroxychloroquine for the treatment of Covid-19.
The board issued an opinion last year leaving doctors, in agreement with patients, to decide to use the drug in an “off-label” manner, outside of what is described in the package leaflet. Even Bolsonaro cited the release.
Doctors and scientific and medical bodies began to condemn the position of the Council of Foreign Ministers, for not reprimanding a position that conflicts with scientific knowledge.
“The Brazilian Society for Infectious Diseases does not recommend early treatment of Covid-19 with any medicine because randomized clinical studies with control groups in place to date have not shown any benefit, plus some of these medicines can cause side effects,” the entity said in a January 14 post. / January on social media.
“I will submit a request for a meeting of the Federal Board of Medicine, which has had a very detrimental role in this process,” said the senator to Fulha.